close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade
Kodu・Aktsiate loetelu・Nanobiotix
Search

Nanobiotix

Suletud

17.9 3.71

Osta

Hinna uuendus 7. jaan 2026, 16:29 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

16.44

Max

18.16

Põhinäitajad

By Trading Economics

Sissetulek

-5.4M

Müük

27M

Kasumimarginaal

-20.208

Töötajad

103

EBITDA

1.1M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+39.21% upside

Turustatistika

By TradingEconomics

Turukapital

877M

Eelmine avamishind

14.19

Eelmine sulgemishind

17.9

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. jaan 2026, 21:14 UTC

Suurimad hinnamuutused turgudel

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

DJ

Loe

6. jaan 2026, 19:23 UTC

Omandamised, ülevõtmised, äriostud

OneStream to Go Private Through $6.4 Billion Hg Acquisition

DJ

Loe

6. jaan 2026, 17:41 UTC

Suurimad hinnamuutused turgudel

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

DJ

Loe

6. jaan 2026, 15:46 UTC

Omandamised, ülevõtmised, äriostud

Advent International Leads InPost Takeover Offer, Sky News Says

DJ

Loe

6. jaan 2026, 15:37 UTC

Suurimad hinnamuutused turgudel

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

DJ

Loe

6. jaan 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

DJ

Loe

6. jaan 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

DJ

Loe

6. jaan 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

DJ

Loe

6. jaan 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

DJ

Loe

6. jaan 2026, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

DJ

Loe

6. jaan 2026, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

DJ

Loe

6. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

6. jaan 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

6. jaan 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

DJ

Loe

6. jaan 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

DJ

Loe

6. jaan 2026, 20:59 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

DJ

Loe

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

DJ

Loe

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

DJ

Loe

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Deal Could Be Announced Imminently, Sources Say -- WSJ

DJ

Loe

6. jaan 2026, 20:40 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

DJ

Loe

6. jaan 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

DJ

Loe

6. jaan 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

DJ

Loe

6. jaan 2026, 19:46 UTC

Omandamised, ülevõtmised, äriostud

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

DJ

Loe

6. jaan 2026, 19:08 UTC

Omandamised, ülevõtmised, äriostud

OneStream to Go Private Through $6.4B Hg Acquisition

DJ

Loe

6. jaan 2026, 18:28 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

DJ

Loe

6. jaan 2026, 17:20 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

DJ

Loe

6. jaan 2026, 17:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

DJ

Loe

6. jaan 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

DJ

Loe

6. jaan 2026, 15:34 UTC

Market Talk
Tulu

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

DJ

Loe

6. jaan 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

DJ

Loe

Nanobiotix Prognoos

Hinnasiht

By TipRanks

39.21% tõus

12 kuu keskmine prognoos

Keskmine 24 EUR  39.21%

Kõrge 25 EUR

Madal 23 EUR

Põhineb 2 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Põhineb 2 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Keskpikk perspektiiv

Weak Bearish Evidence

Bearish events outweigh bullish events.

Pikk perspektiiv

Weak Bearish Evidence

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
help-icon Live chat